Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 4/20 | 0.72 |
| ▸ | DPP4 | P27487 | 2/20 | 0.72 |
| ▸ | F2 | P00734 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oenin SCHEMBL29521448 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL676018 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29468973 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL6139047 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29894980 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL662772 | 0.99 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL723403 | 0.98 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29881103 | 0.98 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL1096836 | 0.98 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| SCHEMBL30901362 | 0.97 | CD38 (0.75) | CD38DPP4F2MAOATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118914413-B | Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi | 海南省农业科学院三亚研究院(海南省实验动物研究中心) | 2024-12-03 | — | — | CN | claimed |
| CN-118914413-A | Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi | 海南省农业科学院三亚研究院(海南省实验动物研究中心) | 2024-11-08 | — | — | CN | claimed |
| US-20240350574-A1 | PHENOLIC PHYTOCHEMICALS FOR BONE METASTASIS OF CANCER | NDSU RESEARCH FOUNDATION | 2024-10-24 | — | — | US | claimed |
| CN-116870046-B | Use of natural compounds and derivatives thereof for the treatment of arterial lesions | 中国科学院上海药物研究所 | 2024-09-20 | — | — | CN | claimed |
| CN-118382694-A | Methods and compositions for generating human erythroid progenitors | 特雷尔赫德生物系统股份有限公司 | 2024-07-23 | — | — | CN | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| CN-116870046-A | Use of natural compounds and derivatives thereof for the treatment of arterial lesions | 中国科学院上海药物研究所 | 2023-10-13 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-11712056-B2 | Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases | VALBIOTIS (FR) | 2023-08-01 | — | — | US | claimed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | claimed |
| US-10232005-B2 | Compositions and methods for controlling carbohydrate and fat metabolism | UNIVERSITE CLERMONT AUVERGNE (FR) | 2019-03-19 | — | — | US | claimed |
| US-9962420-B2 | Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism | VALBIOTIS (FR) | 2018-05-08 | — | — | US | claimed |
| US-20170028004-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | UNIVERSITE CLERMONT AUVERGNE (FR) | 2017-02-02 | — | — | US | claimed |
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | UNIVERSITE CLERMONT AUVERGNE (FR) | 2016-04-21 | — | — | US | claimed |
| EP-2976061-A1 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | Dentalmed Pharm Holding Ltd. (BE) | 2016-01-27 | — | — | EP | claimed |
| WO-2014147613-A1 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | DENTALMED PHARM HOLDING LTD. (BE) | 2014-09-25 | — | — | WO | claimed |
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | NIH - DEITR | 2009-07-09 | — | — | US | claimed |
| WO-2009059218-A1 | BERRY PREPARATIONS FOR TREATMENT OF DIABETES AND METABOLIC SYNDROME | PHYTOMEDICS, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20020054924-A1 | Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor | LEAHY MARGARET M (US) | 2002-05-09 | — | — | US | claimed |
| WO-2001080870-A2 | COMPOSITIONS DERIVED FROM CRANBERRY AND GRAPEFRUIT AND THERAPEUTIC USES THEREFOR | OCEAN SPRAY CRANBERRIES, INC. (US) | 2001-11-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10232005-B2 | Compositions and methods for controlling carbohydrate and fat metabolism | PLIN3, GYS1, PCK1 | CD38 331/4885DPP4 1479/4885F2 1244/4885 |
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | PLIN3, GYS1, PLIN5 | CD38 348/4885DPP4 1009/4885F2 1238/4885 |
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | GPR119, FABP4, GYS2 | CD38 740/4885DPP4 109/4885F2 1393/4885 |
| US-20170028004-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | PLIN3, GYS1, PLIN5 | CD38 348/4885DPP4 1009/4885F2 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.